Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001999371-25-010859·ANAPTYSBIO, INC
Schedule 13G ownership disclosure
AnaptysBio Inc
Common Stock, $0.01 par value · CUSIP: 032724106
Event date: 2025-07-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- First Light Asset Management, LLC
Shares: 2,133,903.00 · Class: 7.26%
- Mathew P. Arens
Shares: 2,265,903.00 · Class: 7.71%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001999371-25-010859
- Form type
- SCHEDULE 13G/A
- Filer
- ANAPTYSBIO, INC
- CIK
- CIK 1370053
- Filed
- Aug 07, 2025
- Reporting period
- Jul 31, 2025
- Description
- Schedule 13G beneficial ownership